| 1391 |
1297: Activation, insulin receptor |
1298: Activation, mTORC2 |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1051 |
762: Activation, ionotropic GABA Receptor chloride channel |
761: Increased, Chloride conductance |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1369 |
1282: Activation, JAK/STAT pathway |
1283: Activation, TGF-beta pathway |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1380 |
1292: Activation, JNK |
1293: Activation, FOXO |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 2149 |
1292: Activation, JNK |
1793: AP-1 activation |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 2150 |
1292: Activation, JNK |
1794: Pin-1 activation |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 1261 |
1205: Activation, Juvenile hormone receptor |
1206: Induction, Doublesex1 gene |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 834 |
826: Activation, Keratinocytes |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1401 |
1302: Activation, L-FABP |
1305: Increase, cytosolic fatty acid |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1423 |
1302: Activation, L-FABP |
228: demethylation, PPARg promoter |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 1651 |
1468: TGFbeta1 activation |
1469: TGFbeta pathway activation |
Aug 16, 2017 |
Aug 16, 2017 |
1 AOP
|
| 172 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 874 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
853: Changes/Inhibition, Cellular Homeostasis and Apoptosis |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 875 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
854: Alterations, Cellular proliferation / hyperplasia |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 876 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
856: Formation, Hepatocellular and Bile duct tumors |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 1425 |
1314: Activation, LRH-1 |
116: Activation, FAS |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 173 |
167: Activation, LXR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 174 |
167: Activation, LXR |
66: Activation, ChREBP |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 175 |
167: Activation, LXR |
116: Activation, FAS |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 176 |
167: Activation, LXR |
258: Activation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 177 |
167: Activation, LXR |
264: Activation, SREBP-1c |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 479 |
167: Activation, LXR |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 490 |
167: Activation, LXR |
463: Up Regulation, FAS |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 491 |
167: Activation, LXR |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 510 |
167: Activation, LXR |
468: Inhibition, PPAR alpha |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|